Avantor (AVTR) Resumen de Acciones
Avantor, Inc. se dedica al suministro de productos y servicios de misión crítica a clientes de los sectores biofarmacéutico, sanitario, educativo y gubernamental, tecnologías avanzadas y materiales aplicados en América, Europa, Asia, Oriente Medio y África. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 4/6 |
| Crecimiento futuro | 3/6 |
| Rendimiento pasado | 0/6 |
| Salud financiera | 2/6 |
| Dividendos | 0/6 |
AVTR Community Fair Values
Create NarrativeSee what 16 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Competidores de Avantor, Inc.
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$13.96 |
| Máximo en las últimas 52 semanas | US$15.93 |
| Mínimo de 52 semanas | US$7.27 |
| Beta | 0.89 |
| Cambio en 1 mes | 30.96% |
| Variación en 3 meses | 77.38% |
| Cambio de 1 año | 8.39% |
| Variación en 3 años | -35.76% |
| Variación en 5 años | -64.54% |
| Variación desde la OPV | -3.72% |
Noticias y actualizaciones recientes
Actualización de narrativa • Aug 14
AVTR: Turnaround Progress And Sector Tailwinds Will Likely Define Next Phase
Analysts have lifted the Avantor fair value estimate from $10.31 to $14.56 after a series of price target increases across the Street. This reflects updated views on discount rate, revenue growth, profit margin, and future P/E assumptions following recent Q2 results and turnaround progress.
Actualización de narrativa • Jul 30
AVTR: Turnaround Execution And Sector Recovery Will Support Future Repricing
Analysts have raised Avantor's fair value estimate from $15.99 to $17.94, reflecting higher price targets across the Street following Q2 results and a management turnaround that is starting to appear in reported margins and growth assumptions. Analyst Commentary Recent Street commentary around Avantor has shifted toward a more constructive tone, with several firms resetting price targets higher following the latest Q2 earnings and early signs of progress under the new leadership team.Recent updates
Actualización de narrativa • Aug 14
AVTR: Turnaround Progress And Sector Tailwinds Will Likely Define Next Phase
Analysts have lifted the Avantor fair value estimate from $10.31 to $14.56 after a series of price target increases across the Street. This reflects updated views on discount rate, revenue growth, profit margin, and future P/E assumptions following recent Q2 results and turnaround progress.Actualización de narrativa • Jul 30
AVTR: Turnaround Execution And Sector Recovery Will Support Future Repricing
Analysts have raised Avantor's fair value estimate from $15.99 to $17.94, reflecting higher price targets across the Street following Q2 results and a management turnaround that is starting to appear in reported margins and growth assumptions. Analyst Commentary Recent Street commentary around Avantor has shifted toward a more constructive tone, with several firms resetting price targets higher following the latest Q2 earnings and early signs of progress under the new leadership team.Actualización de narrativa • Jul 14
AVTR: Sector Tailwinds And Execution Risks Will Likely Shape Next Phase
Avantor's updated analyst price target moves from $9.92 to $10.31, with analysts citing refreshed sector views, recent target hikes into the $10.50 to $11 range, and a higher assumed future P/E multiple as key supports for the revised valuation framework. Analyst Commentary Recent research on Avantor reflects a split view, with some analysts pointing to improving sector conditions and revised price targets, while others focus on ongoing growth and margin challenges.Artículo de análisis • Jun 17
Avantor (AVTR) Stock Could Be 34% Below Fair Value After Wolfe Research Downgrade
Wolfe Research’s new Underperform rating on Avantor (AVTR) has put fresh attention on the stock, as the firm pointed to ongoing growth and margin pressures, as well as market share losses in its VWR distribution business. See our latest analysis for Avantor. Avantor’s recent 1 day share price return declined 1.44%, extending a 7 day share price return decline of 3.43%. However, the 30 day share price return rose 25.59%, while the 1 year total shareholder return declined 27.22%. This indicates...
Actualización de narrativa • Jun 15
AVTR: Compressed Margins And Shrinking Real Revenue Will Weigh On Future Returns
Analysts have trimmed the fair value estimate for Avantor to $7.00, reflecting a series of lower price targets and continued concerns about shrinking real revenue, margin compression, and execution risk, even though some expectations remain for improved growth and profitability over time. Analyst Commentary Recent Street research on Avantor has leaned cautious, with several bearish analysts cutting price targets and highlighting ongoing operational and profitability challenges.Actualización de narrativa • Jun 01
AVTR: Reset Expectations And Quality Expansion Will Support Turnaround Execution And Repricing
Analysts have trimmed Avantor's fair value estimate by about $0.48 to $15.99, as recent price target cuts and concerns about execution, market share trends, and confidence in the turnaround story temper prior expectations. Analyst Commentary Street research on Avantor has centered on whether the current share price already reflects execution risk and the uncertainties around the turnaround plan.Actualización de narrativa • May 01
AVTR: Reset Expectations And Execution Progress May Support Future Upside
Avantor's updated analyst price target moves lower by several dollars to reflect a reset in fair value to $9.92, as analysts reference reduced price targets across the Street and ongoing questions around market share trends and management execution. Analyst Commentary Recent Street research around Avantor clusters around lower price targets and a downgrade in rating, with most comments focused on valuation reset, market share questions, and confidence in management execution.Seeking Alpha • Apr 30
Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible
Summary Avantor, Inc. reported a slight beat on 1Q26 EPS and revenue, but underlying organic growth and margins remain under pressure. Negative organic growth, margin compression, and subdued cash flow signal only early stabilization, not a confirmed recovery, especially in the VWR segment. Management reaffirmed 2026 guidance and expects sequential improvement, but the recovery is execution-dependent and gradual, with margins likely to remain below historical peaks. Valuation screens as discounted, but low multiples reflect market skepticism about AVTR’s growth durability and margin structure; a hold rating is maintained pending clearer evidence of turnaround. Read the full article on Seeking AlphaActualización de narrativa • Apr 16
AVTR: Expanded Quality Control Capabilities Will Support Execution Turnaround And Future Share Repricing
Analysts have trimmed their average price targets on Avantor, and the updated fair value estimate now stands at about $16.47. This reflects a softer sentiment around the stock as research notes point to share losses, reduced investment, and questions about management's ability to stabilize the business.Actualización de narrativa • Apr 02
AVTR: Reset Expectations And Share Repurchases May Support Future Upside
The analyst price target for Avantor has shifted lower to reflect a series of Street target cuts, including a move to $8.50. This change stems from concerns about share losses, constrained investment, and uncertainty over whether management can stabilize the business.Actualización de narrativa • Mar 19
AVTR: Execution Turnaround In Core Franchise Will Drive Future Share Repricing
Analysts have lowered their price targets on Avantor, with the updated fair value estimate moving from about $17.68 to $16.13 as they factor in concerns about share losses, underinvestment, and uncertainty around management's ability to stabilize the business, along with a higher assumed discount rate and P/E multiple. Analyst Commentary Recent Street research has tilted cautious on Avantor, highlighted by a downgrade to Underweight with a US$8.50 price target and several cuts to prior price targets.Actualización de narrativa • Mar 05
AVTR: Reset Expectations And Buybacks Will Support Future Upside Potential
Analysts have cut their average price target on Avantor by a few dollars to reflect lower fair value estimates, softer assumed revenue growth and profit margins, and a higher future P/E multiple in light of recent broad target reductions from firms across the Street. Several have moved targets in a $2 to $4 range, and one reset its view from $14 to $12.Artículo de análisis • Feb 13
The Market Doesn't Like What It Sees From Avantor, Inc.'s (NYSE:AVTR) Revenues Yet As Shares Tumble 27%
Avantor, Inc. ( NYSE:AVTR ) shares have had a horrible month, losing 27% after a relatively good period beforehand...Actualización de narrativa • Feb 04
AVTR: Service Expansion And Execution Will Drive Upside From Reset Expectations
Narrative Update: Avantor Analyst Price Target Shift Analysts recently trimmed their price target on Avantor to $12 from $14. This reflects updated views on the life science tools sector and a Q4 outlook where many companies have already set softer expectations for 2026.Actualización de narrativa • Jan 21
AVTR: Share Repurchases And Execution Risks Will Shape Turnaround Visibility
Analysts have trimmed their price target on Avantor by about $0.60, reflecting more cautious assumptions on revenue growth and future P/E. This is partly offset by slightly higher profit margin expectations and a marginally lower discount rate.Actualización de narrativa • Jan 07
AVTR: Execution Turnaround And Review Process Will Unlock Share Repricing Potential
Avantor's analyst price targets and fair value estimates have inched higher to around $17.68 per share. At the same time, lower assumed revenue growth, a higher discount rate, a reduced future P/E, and sharply higher profit margin expectations reflect analysts' mixed views following recent downgrades and concerns about execution and visibility.Actualización de narrativa • Dec 14
AVTR: Share Repurchases Will Drive Upside As Turnaround Visibility Improves
Analysts have modestly lowered their price targets on Avantor by a few dollars per share, generally to the low to mid teens in dollar terms. They cite reduced guidance, weaker quarters and limited visibility around the company’s turnaround and strategic review.Actualización de narrativa • Nov 28
AVTR: Share Repurchase Initiative And Execution Will Shape Recovery Prospects Ahead
Analysts have lowered their price target for Avantor from $14 to $12 per share, citing a weak quarter, reduced guidance, and ongoing execution risks as primary concerns behind the updated outlook. Analyst Commentary Bullish Takeaways Bullish analysts have raised price targets ahead of quarterly results, reflecting improved confidence in Avantor’s long-term positioning despite current volatility.Actualización de narrativa • Nov 14
AVTR: Share Repurchase And Execution Will Define Turnaround Prospects In 2025
Avantor’s analyst price target has decreased from $13.80 to $13.64. Analysts cite reduced company guidance, execution risks, and ongoing uncertainty surrounding its earnings outlook as key factors driving the revision.Artículo de análisis • Nov 01
Avantor, Inc. Reported A Surprise Loss, And Analysts Have Updated Their Forecasts
There's been a major selloff in Avantor, Inc. ( NYSE:AVTR ) shares in the week since it released its third-quarter...Actualización de narrativa • Oct 31
AVTR: Activist Pressure And Business Overhaul Will Drive Share Recovery
Avantor’s analyst price target has been reduced from $14.40 to $13.80 per share, as analysts cite ongoing operational headwinds and limited near-term earnings visibility following recent downgrades and mixed guidance. Analyst Commentary Recent analyst notes on Avantor capture a divided outlook, reflecting both positive updates from some firms and notable caution from others as the company contends with ongoing operational challenges.Artículo de análisis • Oct 28
There's No Escaping Avantor, Inc.'s (NYSE:AVTR) Muted Earnings Despite A 28% Share Price Rise
Avantor, Inc. ( NYSE:AVTR ) shares have had a really impressive month, gaining 28% after a shaky period beforehand...Actualización de narrativa • Oct 16
Pharma Contracts And R&D Will Drive Growth Amid Price Pressures
Analysts have modestly increased their price target for Avantor, raising it by $0.28 to $14.40. They cite revised expectations for end market recovery and alignment with company outlooks.Artículo de análisis • Sep 12
We Think Avantor (NYSE:AVTR) Is Taking Some Risk With Its Debt
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' When we think about how risky a company...Seeking Alpha • Apr 26
Avantor: A Healthier Diagnosis As Expectations Cool
Summary Avantor's shares have nearly halved since October, driven by lackluster organic growth, elevated debt, and a mixed financial track record. The company operates in two segments, generating nearly $7 billion in sales, with significant exposure to laboratory solutions and bioscience production. Despite a reduction in net debt and lower earnings multiples, the business faces ongoing challenges, including flat organic growth and a high leverage ratio. The risk-reward profile has improved due to lower expectations, but the outlook remains cautious amidst continued sales declines and pending leadership changes. Read the full article on Seeking AlphaSeeking Alpha • Mar 07
Avantor: Mundane Business, Solid Cash Flow, Potential New Risks
Summary Avantor, Inc. has seen a significant decline in its stock price recently. The company did divest itself of one business this summer, paying down some debt with the proceeds. In addition, the company delivered an impressive amount of free cash flow in FY2024. Buy, Sell or Hold? An analysis around AVTR stock follows in the paragraphs below. Read the full article on Seeking AlphaSeeking Alpha • Dec 18
Avantor: Durable FCF Generator Trading For Cheap
Summary Avantor's robust business model yields stable cash flows and generates sticky customers. Avantor’s leadership in the biopharma industry and shifting revenue mix can produce considerable margin expansion. Significant FCF generation can improve the company’s capital structure and return value to shareholders. Potential industry inflection point creates optimal entry point with multiple expansion. Read the full article on Seeking AlphaRentabilidad de los accionistas
| AVTR | US Life Sciences | Mercado US | |
|---|---|---|---|
| 7D | 0.2% | 2.6% | -0.8% |
| 1Y | 8.4% | 23.0% | 20.5% |
Rentabilidad vs. Industria: Los resultados de AVTR fueron inferiores a los de la industria US Life Sciences, que obtuvo un rendimiento del 16.6% el año pasado.
Rentabilidad vs. Mercado: AVTR obtuvo unos resultados inferiores a los del mercado US, que fueron del 19.9% el año pasado.
Volatilidad de los precios
| AVTR volatility | |
|---|---|
| AVTR Average Weekly Movement | 7.7% |
| Life Sciences Industry Average Movement | 8.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.4% |
| 10% least volatile stocks in US Market | 3.1% |
Precio estable de las acciones: AVTR no ha tenido una volatilidad de precios significativa en los últimos 3 meses en comparación con el mercado US.
Volatilidad a lo largo del tiempo: La volatilidad semanal de AVTR (8%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1904 | 13,500 | Emmanuel Ligner | www.avantorsciences.com |
Avantor, Inc. se dedica al suministro de productos y servicios de misión crítica a clientes de los sectores biofarmacéutico, sanitario, educativo y gubernamental, tecnologías avanzadas y materiales aplicados en América, Europa, Asia, Oriente Medio y África. La empresa ofrece materiales y consumibles, como productos químicos y reactivos de pureza, productos y suministros de laboratorio, materiales de silicona formulados, excipientes personalizados, conjuntos de un solo uso personalizados, resinas y columnas de cromatografía de procesos, kits de preparación de muestras analíticas, productos de educación y microbiología, kits de ensayos clínicos y puntas de manipulación de fluidos. También ofrece equipos y productos de instrumentación, como sistemas de filtración, sistemas de inactivación de virus, incubadoras, instrumentos analíticos, evaporadores, congeladores de temperatura ultrabaja, cabinas de seguridad biológica, bombas peristálticas y suministros para entornos críticos.
Resumen de fundamentos de Avantor, Inc.
| Estadísticas fundamentales de AVTR | |
|---|---|
| Capitalización bursátil | US$9.02b |
| Beneficios(TTM) | -US$578.00m |
| Ingresos (TTM) | US$6.56b |
1.4x
Ratio precio-ventas (PS)-16.3x
Ratio precio-beneficio (PE)¿Está AVTR sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de AVTR | |
|---|---|
| Ingresos | US$6.56b |
| Coste de los ingresos | US$4.47b |
| Beneficio bruto | US$2.09b |
| Otros gastos | US$2.67b |
| Beneficios | -US$578.00m |
Últimos beneficios comunicados
Jun 30, 2026
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.85 |
| Margen bruto | 31.83% |
| Margen de beneficio neto | -8.81% |
| Ratio deuda/patrimonio | 65.2% |
¿Cómo se ha desempeñado AVTR a largo plazo?
Ver rendimiento histórico y comparativaAnálisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/08/19 02:13 |
| Precio de las acciones al final del día | 2026/08/19 00:00 |
| Beneficios | 2026/06/30 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Avantor, Inc. está cubierta por 29 analistas. 15 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Robert Bamberger | Baird |
| Catherine Ramsey Schulte | Baird |
| Luke Sergott | Barclays |